Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuminori Sakurai

Showing results (101-110 of 170) with videos related to

Pageof 17
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2017
miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene TherapyTakayuki Suzuki, Fuminori Sakurai, Shin-Ichiro Nakamura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2009
Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectorsMasahiro Ushitora, Fuminori Sakurai, Tomoko Yamaguchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primatesFuminori Sakurai, Shin-ichiro Nakamura, Kimiyo Akitomo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2008
miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapyTakayuki Suzuki, Fuminori Sakurai, Shin-ichiro Nakamura, et al.
Clinical and Experimental Nephrology|October 30, 2020
Preoperative CT volumetry of estimated residual kidney for prediction of postoperative chronic kidney disease in patients with renal cell carcinomaYutaro Hori, Daisuke Obinata, Daigo Funakoshi, et al.
Cancer Science|April 10, 2022
Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatmentHiroshi Tazawa, Kunitoshi Shigeyasu, Kazuhiro Noma, et al.
Biochemical and Biophysical Research Communications|November 19, 2011
Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infectionTakeshi Yoshida, Kazuo Takayama, Masuo Kondoh, et al.
Molecular Pharmaceutics|November 7, 2012
Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination systemDavid Bennett, Fuminori Sakurai, Kahori Shimizu, et al.
Stem Cell Reports|December 10, 2013
Long-term self-renewal of human ES/iPS-derived hepatoblast-like cells on human laminin 111-coated dishesKazuo Takayama, Yasuhito Nagamoto, Natsumi Mimura, et al.
International Journal of Pharmaceutics|April 9, 2017
Cationic liposome-mediated delivery of reovirus enhances the tumor cell-killing efficiencies of reovirus in reovirus-resistant tumor cellsFuminori Sakurai, Shunsuke Inoue, Tadataka Kaminade, et al.
Pageof 17

Showing results (101-110 of 170) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2017
miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene TherapyTakayuki Suzuki, Fuminori Sakurai, Shin-Ichiro Nakamura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2009
Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectorsMasahiro Ushitora, Fuminori Sakurai, Tomoko Yamaguchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2008
Transduction properties of adenovirus serotype 35 vectors after intravenous administration into nonhuman primatesFuminori Sakurai, Shin-ichiro Nakamura, Kimiyo Akitomo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 31, 2008
miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapyTakayuki Suzuki, Fuminori Sakurai, Shin-ichiro Nakamura, et al.
Clinical and Experimental Nephrology|October 30, 2020
Preoperative CT volumetry of estimated residual kidney for prediction of postoperative chronic kidney disease in patients with renal cell carcinomaYutaro Hori, Daisuke Obinata, Daigo Funakoshi, et al.
Cancer Science|April 10, 2022
Tumor-targeted fluorescence labeling systems for cancer diagnosis and treatmentHiroshi Tazawa, Kunitoshi Shigeyasu, Kazuhiro Noma, et al.
Biochemical and Biophysical Research Communications|November 19, 2011
Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infectionTakeshi Yoshida, Kazuo Takayama, Masuo Kondoh, et al.
Molecular Pharmaceutics|November 7, 2012
Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination systemDavid Bennett, Fuminori Sakurai, Kahori Shimizu, et al.
Stem Cell Reports|December 10, 2013
Long-term self-renewal of human ES/iPS-derived hepatoblast-like cells on human laminin 111-coated dishesKazuo Takayama, Yasuhito Nagamoto, Natsumi Mimura, et al.
International Journal of Pharmaceutics|April 9, 2017
Cationic liposome-mediated delivery of reovirus enhances the tumor cell-killing efficiencies of reovirus in reovirus-resistant tumor cellsFuminori Sakurai, Shunsuke Inoue, Tadataka Kaminade, et al.
Pageof 17